Literature DB >> 24012566

Immunisation with ID83 fusion protein induces antigen-specific cell mediated and humoral immune responses in cattle.

Gareth J Jones1, Sabine Steinbach, Derek Clifford, Susan L Baldwin, Gregory C Ireton, Rhea N Coler, Steven G Reed, H Martin Vordermeier.   

Abstract

In this study we have investigated the potential of mycobacterial proteins as candidate subunit vaccines for bovine tuberculosis. In addition, we have explored the use of TLR-ligands as potential adjuvants in cattle. In vitro screening assays with whole blood from Mycobacterium bovis-infected and BCG-vaccinated cattle demonstrated that fusion protein constructs were most commonly recognised, and the ID83 fusion protein was selected for further immunisation studies. Furthermore, glucopyranosyl lipid A (GLA) and resiquimod (R848), agonists for TLR4 and TLR7/8 respectively, stimulated cytokine production (IL-12, TNF-α, MIP-1β and IL-10) in bovine dendritic cell cultures, and these were formulated as novel oil-in-water emulsions (GLA-SE and R848-SE) for immunisation studies. Immunisation with ID83 in a water-in-oil emulsion adjuvant (ISA70) induced both cell mediated and humoral immune responses, as characterised by antigen-specific IFN-γ production, cell proliferation, IgG1 and IgG2 antibody production. In comparison, ID83 immunisation with the novel adjuvants induced weaker (ID83/R848-SE) or no (ID83/GLA-SE) antigen-specific IFN-γ production and cell proliferation. However, both did induce ID83-specific antibody production, which was restricted to IgG1 antibody isotype. Overall, these results provide encouraging preliminary data for the further development of ID83 in vaccine strategies for bovine TB. Crown
Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adjuvants; Bovine tuberculosis; Mycobacterium bovis; Vaccine

Mesh:

Substances:

Year:  2013        PMID: 24012566      PMCID: PMC3855245          DOI: 10.1016/j.vaccine.2013.08.051

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  29 in total

Review 1.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

2.  Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848.

Authors:  Marion Jurk; Florian Heil; Jörg Vollmer; Christian Schetter; Arthur M Krieg; Hermann Wagner; Grayson Lipford; Stefan Bauer
Journal:  Nat Immunol       Date:  2002-06       Impact factor: 25.606

3.  Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod.

Authors:  Sheila J Gibson; Jana M Lindh; Tony R Riter; Raymond M Gleason; Lisa M Rogers; Ashley E Fuller; JoAnn L Oesterich; Keith B Gorden; Xiaohong Qiu; Scott W McKane; Randy J Noelle; Richard L Miller; Ross M Kedl; Patricia Fitzgerald-Bocarsly; Mark A Tomai; John P Vasilakos
Journal:  Cell Immunol       Date:  2002 Jul-Aug       Impact factor: 4.868

4.  Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.

Authors:  Hiroaki Hemmi; Tsuneyasu Kaisho; Osamu Takeuchi; Shintaro Sato; Hideki Sanjo; Katsuaki Hoshino; Takao Horiuchi; Hideyuki Tomizawa; Kiyoshi Takeda; Shizuo Akira
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

5.  Development of diagnostic reagents to differentiate between Mycobacterium bovis BCG vaccination and M. bovis infection in cattle.

Authors:  H M Vordermeier; P C Cockle; A Whelan; S Rhodes; N Palmer; D Bakker; R G Hewinson
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

6.  Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

Authors:  C M Snapper; W E Paul
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

7.  Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells.

Authors:  T L Stevens; A Bossie; V M Sanders; R Fernandez-Botran; R L Coffman; T R Mosmann; E S Vitetta
Journal:  Nature       Date:  1988-07-21       Impact factor: 49.962

8.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

9.  IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.

Authors:  F D Finkelman; I M Katona; T R Mosmann; R L Coffman
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

Review 10.  Novel approaches to vaccine delivery.

Authors:  Derek T O'Hagan; Rino Rappuoli
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

View more
  5 in total

1.  The synergistic effects of combining TLR ligand based adjuvants on the cytokine response are dependent upon p38/JNK signalling.

Authors:  Lucia Fischetti; Ziyun Zhong; Christopher L Pinder; John S Tregoning; Robin J Shattock
Journal:  Cytokine       Date:  2017-08-18       Impact factor: 3.861

2.  Non-specific protection from respiratory tract infections in cattle generated by intranasal administration of an innate immune stimulant.

Authors:  William Wheat; Lyndah Chow; Vanessa Rozo; Julia Herman; Kelly Still Brooks; Aimee Colbath; Randy Hunter; Steven Dow
Journal:  PLoS One       Date:  2020-06-25       Impact factor: 3.240

Review 3.  The potential of the CMB305 vaccine regimen to target NY-ESO-1 and improve outcomes for synovial sarcoma and myxoid/round cell liposarcoma patients.

Authors:  Seth M Pollack
Journal:  Expert Rev Vaccines       Date:  2017-12-27       Impact factor: 5.217

4.  Systematic Evaluation of Mycobacterium tuberculosis Proteins for Antigenic Properties Identifies Rv1485 and Rv1705c as Potential Protective Subunit Vaccine Candidates.

Authors:  Yaguo Wang; Zihui Li; Shucai Wu; Joy Fleming; Chuanyou Li; Guofeng Zhu; Bo Chen; Baiguang Ren; Xingyun Wang; Boping Du; Pingjun Li; Peilei Hu; Juwang Yang; Yi Liu; Chongchen Zhou; Xian-En Zhang; Lijun Bi; Hongtai Zhang; Junmei Yang; Zongde Zhang
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

5.  Evaluation of a Lipopolysaccharide and Resiquimod Combination as an Adjuvant with Inactivated Newcastle Disease Virus Vaccine in Chickens.

Authors:  Bal Krishan Sharma; Saravanan Ramakrishnan; Abinaya Kaliappan; Mithilesh Singh; Ajay Kumar; Satyabrata Dandapat; Sohini Dey; Madhan Mohan Chellappa
Journal:  Vaccines (Basel)       Date:  2022-06-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.